4
Changes in Ownership
Mirum Pharmaceuticals, Inc. Filed Acc 0001197350-26-000009
CHIEF FINANCIAL OFFICER sold 6,001 shares at $99.90 ($599,510)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
BJERKHOLT ERIC · CHIEF FINANCIAL OFFICER
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-08-11 | Sale : show line 1 in the form 10b5-1 | −6,001 | $99.90 | $599,510 | 36,355 | D |
| Open-market sales · 6,001 sh · avg $99.90 · $599,510 | ||||||
Loading xslF345X06/form4-08122026_090835.xml…